ag-1549 and nevirapine

ag-1549 has been researched along with nevirapine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kang, X; Kollman, PA; Kuntz, ID; Wang, J	1
Auwerx, J; Balzarini, J; De Clercq, E; Esnouf, R	1

Other Studies

2 other study(ies) available for ag-1549 and nevirapine

Article	Year
Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA. Journal of medicinal chemistry, 2005, Apr-07, Volume: 48, Issue:7 Topics: Allosteric Site; Anti-HIV Agents; Crystallography, X-Ray; Databases, Factual; Drug Design; HIV Reverse Transcriptase; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Statistics as Topic; Thermodynamics	2005
Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors. Molecular pharmacology, 2004, Volume: 65, Issue:1 Topics: Amino Acid Sequence; Animals; Anti-HIV Agents; Catalysis; Cats; Deoxyguanine Nucleotides; Dideoxynucleotides; Foscarnet; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Immunodeficiency Virus, Feline; Kinetics; Molecular Sequence Data; Nevirapine; Recombinant Fusion Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Homology, Amino Acid; Species Specificity; Sulfur Compounds	2004

Article

Year

Hierarchical database screenings for HIV-1 reverse transcriptase using a pharmacophore model, rigid docking, solvation docking, and MM-PB/SA.

Journal of medicinal chemistry, 2005, Apr-07, Volume: 48, Issue:7

Topics: Allosteric Site; Anti-HIV Agents; Crystallography, X-Ray; Databases, Factual; Drug Design; HIV Reverse Transcriptase; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Binding; Quantitative Structure-Activity Relationship; Reverse Transcriptase Inhibitors; Statistics as Topic; Thermodynamics

2005

Susceptibility of feline immunodeficiency virus/human immunodeficiency virus type 1 reverse transcriptase chimeras to non-nucleoside RT inhibitors.

Molecular pharmacology, 2004, Volume: 65, Issue:1

Topics: Amino Acid Sequence; Animals; Anti-HIV Agents; Catalysis; Cats; Deoxyguanine Nucleotides; Dideoxynucleotides; Foscarnet; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Immunodeficiency Virus, Feline; Kinetics; Molecular Sequence Data; Nevirapine; Recombinant Fusion Proteins; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Homology, Amino Acid; Species Specificity; Sulfur Compounds

2004